VHL Polyclonal Antibody | G-AB-09367

VHL Polyclonal Antibody | G-AB-09367 | Gentaur Antibodies

Overview: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF) , which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Category Type: Polyclonal Antibody

Research Areas: Cancer, Cell Biology, Epigenetics and Nuclear Signaling, Metabolism

Synonyms: VHL, HRCA1, RCA1, VHL1, pVHL, PVHL

Reactivity: Mouse, Rat

Host: Rabbit

Isotype: IgG

Gene ID: 7428

Accession #:

Clonality:

Immunogen: A synthetic peptide of human VHL (NP_937799.1) .

Clone #:

Conjugation: Unconjugated

Swissprot: P40337

Santa Cruz:

Calculated MW: 18 kDa/19 kDa/24 kDa

Observed MW: 24 kDa

Concentration: 1 mg/mL

Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3

Purification method: Affinity purification

Application: WB

Dilution: WB 1:500-1:2000

Storage: Store at -20°C. Avoid freeze / thaw cycles.

VHL Polyclonal Antibody DataSheet